James Vollins's most recent trade in Eiger BioPharmaceuticals Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc | James Vollins | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |